ACM
ELV icon

Advent Capital Management’s Elevance Health ELV Stock Holding History

Advent Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-600
Closed -$231K – 269
2018
Q3 		$231K Buy
+600
New +$156K ﹤0.01% 217
2015
Q2 		– Sell
-150
Closed -$39K – 529
2015
Q1 		$39K Buy
+150
New +$21.4K ﹤0.01% 429

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Advent Capital Management's ELV Position: Q3 2019 in Review

Advent Capital Management sold out of Elevance Health (ELV) in Q3 2019, closing a stake of 5,000 shares — an estimated $1.41M sold.

Advent Capital Management first reported a position in ELV in Q2 2018 and held it in 4 quarters. The position peaked at $2M in Q3 2018. 1,015 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

  • Advent Capital Management reported no remaining Elevance Health position as of Q3 2019 after selling out during the quarter.
  • Advent Capital Management sold 5,000 Elevance Health shares in Q3 2019, an estimated $1.41M.
  • Advent Capital Management first reported a position in Elevance Health in Q2 2018 and held it in 4 quarters.
  • Advent Capital Management's Elevance Health position peaked at $2M in Q3 2018.
  • 1,015 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Advent Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.